3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Sarcoma
10
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma
7
Ovarian Neoplasms
4
Lymphoma, Non-Hodgkin
4
Lung Neoplasms
4
Leukemia
4
Carcinoma, Non-Small-Cell Lung
4
Testicular Neoplasms
3
Small Cell Lung Carcinoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Hodgkin Disease
3
Central Nervous System Neoplasms
3
Testicular Germ Cell Tumor
2
Relapsed Pediatric Solid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphoma, T-Cell, Peripheral
2
Fallopian Tube Neoplasms
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Unresectable Sinonasal Tumors
1
Teratoma
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Spinal Cord Neoplasms
1
Sinonasal Tumors
1
Seminoma
1
Interventions
Cisplatin
44
Paclitaxel
21
Radiotherapy
20
Brachytherapy
19
Carboplatin
18
Bevacizumab
7
Drug Therapy
6
camrelizumab
5
toripalimab
4
nimotuzumab
4
Radiation
4
Neoadjuvant Therapy
4
Gemcitabine
4
tislelizumab
3
sintilimab
3
pembrolizumab
3
apatinib
3
Vaccines
3
TP protocol
3
Surgical Procedures, Operative
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
nedaplatin
2
fludarabine
2
endostar protein
2
anlotinib
2
Topotecan
2
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Mindfulness
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uterine Cervical Neoplasms
×
Ifosfamide
×
Clear all
NCT02422563
2015-04-21
NACOPRAD
Charite University, Berlin, Germany
Phase 3
Unknown
534 enrolled